Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Aleafia Health Inc ALEAF

Aleafia Health Inc. is a Canada-based cannabis company. The Company offers cannabis products in Canada and destined for international markets, including Australia and Germany. The Company operates a virtual medical cannabis clinic staffed by physicians and nurse practitioners, which provide health and wellness services across Canada. It owns three licensed cannabis production facilities and operates a located distribution center all in the province of Ontario, including an outdoor cannabis cultivation facility in Canada. The Company produces a diverse portfolio of cannabis and cannabis derivative products, including dried flower, pre-roll, milled, vapes, oils, capsules, edibles, sublingual strips, and topicals, for sale in Canada in the medical and adult-use markets, and in select international jurisdictions. Its subsidiaries include Aleafia Inc., Canabo Medical Corporation, Aleafia Farms Inc., Emblem Corp., Emblem Cannabis Corporation, GrowWise Health Limited and other.


GREY:ALEAF - Post by User

Comment by DBDETECT0Ron Oct 31, 2020 1:43pm
292 Views
Post# 31818734

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:biological assets

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:biological assets
stocktracker101 wrote: Agreed. We all know Aleafia will never get the multiples Canopy gets.. They have a major cash position and Constellation behind them. But x5 - x6 like you said would give Aleafia $500 million - $600 million market cap or $1.66 - $2.00 / share.. 
That would be increadible if they could pull it off. And again that is based on an average sale price of $1.45/gram with a $0.35/gram (based on last earnings) average cost on their inventory which isnt a stretch at all. Those are more than decent margins..
We shall see.
Hopefully Q3 and the harvest numbers will get investors interested and motivated.
Right now, volume and price action is flat.

christophwaltz wrote:

Let's say 5-6x earnings to be fair to logic and really our own expectations. No one is going to give Aleafia the insane pie-in-the-sky multiples they give to Canopy, unless Aleafia can establish itself as the cannabis company to invest in, as Canopy did. 

Horse first, then cart.

That said, Aleafia's expenses will never equate to that of Canopy, so Aleafia May be able to get earnings per share higher than Canopy ever well. You never know.

 





Those are not unreasonable #'s. I think they'll easily pull it off.
<< Previous
Bullboard Posts
Next >>